Verseon
Pharmaceuticals, -320 Warm Springs Blvd., Fremont, , 94538, California, 47000, United States, 11-50 Employees
Who is VERSEON
Verseon delivers pharmaceutical solutions using proprietary, computer-driven drug discovery platform technology. Through scientific advancements in physics- and chemistry-based modeling, ...
Read More
-
Headquarters: 47000-320 Warm Springs Blvd., Fremont, California, 94538, United States
-
Date Founded: 2002
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO:
Adityo Prakash
Email
Phone
Industry: Pharmaceuticals
SIC Code: 8731
|
NAICS Code: 541714 |
Show More
Verseon Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Verseon
Answer: Verseon's headquarters are located at -320 Warm Springs Blvd., Fremont, , 94538, California, 47000, United States
Answer: Verseon's phone number is FALSE
Answer: Verseon's official website is https://verseon.com
Answer: Verseon's revenue is $1 Million to $5 Million
Answer: Verseon's SIC: 8731
Answer: Verseon's NAICS: 541714
Answer: Verseon has 11-50 employees
Answer: Verseon is in Pharmaceuticals
Answer: Verseon contact info: Phone number: FALSE Website: https://verseon.com
Answer: Verseon delivers pharmaceutical solutions using proprietary, computer-driven drug discovery platform technology. Through scientific advancements in physics- and chemistry-based modeling, Verseons gol is to address the cycle of slow and derivative pharmaceutical developments to create truly novel molecular entities. We innovate beyond the bounds of the known and design, test, and synthesize never-been-seen molecules that may soon become life-changing drugs. We began our mission in 2002 and since have built a proprietary platform that identifies novel potential therapeutics faster and more inexpensively than anyone in the industry. We are changing the way that drugs are made atom by atom. We are currently making great strides in cardiovascular diseases, macular degeneration, oncology, metabolic disorders, and mutation-resistant antivirals with over a dozen drug candidates in active development and one completing Phase 1 clinical trials.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month